Haemodynamic and oxymetric investigations on patients under rate-responsive dual-chamber stimulation during exercise.
Rate-response dual-chamber pacing combines the advantages of atrio-ventricular synchrony and rate adaptation in patients suffering from binodal disease. However, it is not known if patients really benefit from the additional rate response under exercise conditions. Therefore, 15 patients suffering from binodal disease received rate-responsive dual-chamber pacemakers. 1, 3, and 6 months postoperatively haemodynamic parameters and oxygen consumption were measured during treadmill ergometry under conventional (DDD) and rate-modulated AV-universal stimulation (DDDR). Using the NCCOM3-R7 (Osypka) technique, rate (f), cardiac index (CI), stroke volume index (SVI), and the end-diastolic volume index (EDVI) were determined non-invasively. Oxygen consumption (VO2) was measured with the Biotec Oxysuper. Based on preoperative status (NYHA) and ventricular contractility, which was determined by means of echocardiography, the patients were divided into two groups: Group I (n = 8) with normal ventricular contractility demonstrated a moderate increase of intrinsic heart rate during exercise. Group II (n = 7) with impaired ventricular contractility showed only a slight or no increase in intrinsic heart rate. When comparing DDD and DDDR pacing a significant increase of CI and VO2 was found for the rate-modulated pacing mode in group II. The reverse was found for patients of group I. The difference between the two groups was statistically significant. According to these results, only patients with nearly no increase in intrinsic sinus heart rate and impaired ventricular function can be expected to benefit from the additional rate-adaptation of a dual-chamber pacemaker.
Weinhold
C
C
Dept. of Cardiac Surgery, University of Munich-Grosshadern, Germany.
Fülle
P
P
Markewitz
A
A
Steinbeck
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002304:Cardiac Pacing, Artificial; D004867:Equipment Design; D005080:Exercise Test; D005260:Female; D006327:Heart Block / Q000503:physiopathology* / Q000628:therapy*; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D010092:Oximetry; D010101:Oxygen Consumption; D010138:Pacemaker, Artificial